Good Life Advisors’s Convergence Long/Short Equity ETF CLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.14M Buy
219,735
+20,887
+11% +$464K 0.32% 66
2025
Q1
$4.3M Buy
198,848
+39,057
+24% +$888K 0.3% 74
2024
Q4
$3.66M Buy
159,791
+27,844
+21% +$645K 0.27% 80
2024
Q3
$2.94M Buy
131,947
+16,916
+15% +$362K 0.18% 111
2024
Q2
$2.47M Buy
115,031
+97,114
+542% +$2.02M 0.2% 97
2024
Q1
$366K Buy
+17,917
New +$338K 0.03% 306

Other funds holding CLSE

Good Life Advisors's CLSE Position: Q2 2025 in Review

Good Life Advisors increased its Convergence Long/Short Equity ETF (CLSE) stake by 11% in Q2 2025, buying an estimated $464K and bringing the position to 219,735 shares worth $5.14M. The position accounts for 0.32% of the portfolio, ranked #66.

Good Life Advisors first reported a position in CLSE in Q1 2024 and has held it in 6 quarters since. 42 funds tracked by Wall St. Rank hold CLSE as of Q2 2025.

  • Good Life Advisors held 219,735 shares of Convergence Long/Short Equity ETF worth $5.14M as of Q2 2025.
  • Good Life Advisors bought 20,887 Convergence Long/Short Equity ETF shares in Q2 2025, an estimated $464K.
  • Convergence Long/Short Equity ETF made up 0.32% of Good Life Advisors's portfolio in Q2 2025, its #66 holding.
  • Good Life Advisors first reported a position in Convergence Long/Short Equity ETF in Q1 2024 and has held it in 6 quarters since.
  • 42 funds tracked by Wall St. Rank held Convergence Long/Short Equity ETF as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.